<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190831044650N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-02</date_registration>
      <primary_sponsor>Islamic Azad University Qaemshahr Branch</primary_sponsor>
      <public_title>The Effects of spinal stabilization and Vitamin D on the  tumor necrosis factor-α and  interleukin-10 in women with Chronic Low Back Pain</public_title>
      <acronym></acronym>
      <scientific_title>The Effects of spinal stabilization exercise and Vitamin D intake on the levels of tumor necrosis factor-α and  interleukin-10 in women with Chronic Low Back Pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-12-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>48</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45116</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The subjects will be divided into four groups of control, exercise, vitamin D and combination (exercise + vitamin D) using simple randomization table. First a number is assigned to each person. Then, using the random number table of each selected number, it is assigned to one of the groups at random and will continue until the number of individuals in each group is completed. Therefore, the researcher will have no option to change or predict the status of individuals. Random concealment will be done by a third person who does not participate in other stages of intervention, Blinding description: Participants, evaluators, and analysts will be blind. The researcher will administer vitamin D capsules (50,000 units) to vitamin D and combination (vitamin D + exercise) individuals as well as placebo to control and exercise groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>chronic low back pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Exercise group will perform 8 weeks of spinal stabilization exercises consisting of 3 sets of 8 stretching and isometric exercises with one minute rest between exercises, three sessions per week. Each exercise session starts from 3 seconds in the first week to 18 seconds in the fifth week, continuing through the eighth week (with a gradual increase of 3 seconds per week).Also, they will also take a placebo capsule weekly. Intervention 2: Intervention group II: Vitamin D group, who take 50,000 IU of vitamin D capsules  once a week for 8 weeks in a single blind manner. Intervention 3: Intervention group 3: Subjects in this group will have 8 weeks of spinal stabilization exercises similar to the exercise group and will consume 50,000 IU of vitamin D capsules once a week in a single blind manner. Intervention 4: Control group: There is no intervention in the control group and they are given placebo in a single blind manner.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Masoumeh Habibian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7 kilometers from Allameh Tabari Street, Islamic Azad University of Ghaemshahr Branch, Ghaemshahr, Iran.</address>
        <city>Qaemshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4765161964</zip>
        <telephone>+98 11 4224 1041</telephone>
        <email>habibian_m@yahoo.com</email>
        <affiliation>Qaemshahr branch, Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>masoumeh habibian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7km Allameh Tabarasi street, Qaemshahr Branch, Islamic Azad University, Qaemshahr</address>
        <city>Qaemshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4765161964</zip>
        <telephone>+98 11 4224 1041</telephone>
        <email>habibian_m@yahoo.com</email>
        <affiliation>Qaemshahr branch, Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having chronic low back pain for more than three months
Pain score (based on visual analogue scale) moderate
Not having regular exercise for the past six months</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Use of specific drugs
smoking
Pregnancy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Exercise group will perform 8 weeks of spinal stabilization exercises consisting of 3 sets of 8 stretching and isometric exercises with one minute rest between exercises, three sessions per week. Each exercise session starts from 3 seconds in the first week to 18 seconds in the fifth week, continuing through the eighth week (with a gradual increase of 3 seconds per week).Also, they will also take a placebo capsule weekly.</i_keyword>
      <i_keyword>Intervention group II: Vitamin D group, who take 50,000 IU of vitamin D capsules  once a week for 8 weeks in a single blind manner</i_keyword>
      <i_keyword>Intervention group 3: Subjects in this group will have 8 weeks of spinal stabilization exercises similar to the exercise group and will consume 50,000 IU of vitamin D capsules once a week in a single blind manner.</i_keyword>
      <i_keyword>Control group: There is no intervention in the control group and they are given placebo in a single blind manner.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Tumor necrosis factor-α. Timepoint: Prior  and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>Interleukin-10. Timepoint: Prior  and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>C reactive protein. Timepoint: Prior  and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>25- hydroxy vitamin D. Timepoint: Prior  and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>Pain level. Timepoint: Prior  and after interventions. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Severity of disability. Timepoint: Prior  and after interventions. Method of measurement: the oswestry disability Questionnaire.</prim_outcome>
      <prim_outcome>Sleep quality. Timepoint: Prior  and after interventions. Method of measurement: Petersburg Sleep Questionnaire.</prim_outcome>
      <prim_outcome>Quality of Life. Timepoint: Prior  and after interventions. Method of measurement: SF-36 Quality of Life Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Aspartate aminotransferase. Timepoint: Before and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Alkaline phosphatase. Timepoint: Before and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Alanine aminotransferase. Timepoint: Before and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Urea. Timepoint: Before and after interventions. Method of measurement: Urease method.</sec_outcome>
      <sec_outcome>Uric acid. Timepoint: Before and after interventions. Method of measurement: Automatic colorimetric method.</sec_outcome>
      <sec_outcome>Creatinine. Timepoint: Before and after interventions. Method of measurement: Jaffe methods.</sec_outcome>
      <sec_outcome>Triglyceride. Timepoint: Before and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Total cholesterol. Timepoint: Before and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Low-density lipoprotein cholesterol (LDL-C). Timepoint: Before and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>High-density lipoprotein cholesterol (HDL-C). Timepoint: Before and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University Qaemshahr Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-14</approval_date>
        <contact_name>Ethics Committee of Babol branch, Islamic Azad University</contact_name>
        <contact_address>Department of physical education, Qaemshahr branch, Islamic Azad University, Qaemshahr, Iran Qeamshahr Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
